Nano-capsules that can modulate the release of the incorporated substances may have applications in the formulation of functional foods, as well as relevance in food preservation and storage, ...

Clin Drug Invest. 2005;25(7):435-443. Drug absorption and, therefore, the clinical effects of orally administered drugs strongly depend on their mode of transit through the gastrointestinal tract.

Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications. The Food and Drug Administration (FDA) has approved the supplemental New Drug Applications (sNDAs) for ...

The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...

A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors (NCT01193595). A phase I study of R04929097, an oral gamma secretase inhibitor, in combination ...

LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...

Please provide your email address to receive an email when new articles are posted on . The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules ...

DUBLIN--(BUSINESS WIRE)--The "Capsule Endoscopy Market to 2027 - Global Analysis and Forecasts by Product; Formulation; End Users, and Geography" report has been added to ResearchAndMarkets.com's ...

Softgel Capsules Market · GlobeNewswire Inc. Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Softgel Capsules Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.

Twenty-four healthy subjects (12 male and 12 female) were included in the trial. They were aged between 22 and 45 (mean 34.4) years, and had body mass indexes of 19.0-28.8 (mean 24.7) kg/m 2. Major ...